MedTrace Logo

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

NCT07195656 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2026-02-06

No results posted yet for this study

Summary

A study to evaluate the safety and effectiveness of FemPulse System

Conditions

  • Overactive Bladder (OAB)

Interventions

DEVICE

Device Group

non-implanted, vaginal electrical stimulation device

DRUG

Medication Group

OAB Medication

Sponsors & Collaborators

  • Moxie Clinical

    collaborator UNKNOWN

  • FemPulse Corporation

    lead INDUSTRY

Principal Investigators

  • Suzette Sutherland, MD · FemPulse Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2027-05-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07195656 on ClinicalTrials.gov